Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06152081 · ClinicalTrials.gov registry record · NA

Caries Detection With Two Different Caries Detecting Devices

A NA study of Caries,Dental, sponsored by Tufts University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06152081: Recruiting NA study of Caries,Dental, sponsored by Tufts University.

NCT06152081 is a NA study of Caries,Dental that is actively recruiting participants, run by Tufts University. The registered enrollment target is 60 participants, below the 587-participant average among 3 other Caries,Dental trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06152081, a NA study of Caries,Dental, is actively recruiting participants, sponsored by Tufts University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study will be to compare the effectiveness of the novel LumiCare™ rinse and with QLF in determining caries progression. The secondary aim is to compare the progression of carious lesions between patients who reported use of e-cigarettes/vapes and those who did not.

Primary Outcome

Compare the effectiveness of the two caries detecting devices in their ability determining caries progression

Conditions Studied

Interventions

  • DEVICE LumiCare rinse
  • DEVICE QLF Inspektor Pro Imaging

Study Locations (1)

Massachusetts

  • Tufts University School of Dental Medicine - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-04-01
Est. Completion 2027-10
Phase NA
Tufts University

163 total trials

What NCT06152081 shows while recruiting

NCT06152081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 587-participant average among 3 other Caries,Dental trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Caries,Dental appearing as the primary indexed condition, and to 2 interventions - of which LumiCare rinse is the first listed.

NCT06152081 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06152081 about?

NCT06152081 is a clinical study titled "Caries Detection With Two Different Caries Detecting Devices". The primary aim of this study will be to compare the effectiveness of the novel LumiCare™ rinse and with QLF in determining caries progression. The secondary aim is to compare the progression of carious lesions between patients who reported use of e-cigarettes/vapes and those who did not.

What is the current status of trial NCT06152081?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-04-01. Estimated completion is 2027-10.

What conditions does trial NCT06152081 study?

This clinical trial studies the following conditions: Caries,Dental.

What interventions are being tested in trial NCT06152081?

The interventions under investigation include: LumiCare rinse (DEVICE), QLF Inspektor Pro Imaging (DEVICE).

Who is sponsoring clinical trial NCT06152081?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06152081 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caries,Dental

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06152081, the US trial registry maintained by the National Library of Medicine. NCT06152081 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.